Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Update

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) saw a significant increase in short interest in March. As of March 15th, there was short interest totalling 500 shares, an increase of 400.0% from the February 29th total of 100 shares. Based on an average daily volume of 4,000 shares, the days-to-cover ratio is presently 0.1 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Price Performance

NASDAQ:HROWM opened at $26.63 on Thursday. The stock has a 50 day simple moving average of $26.01 and a 200 day simple moving average of $25.68. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 1-year low of $22.71 and a 1-year high of $27.72.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 31st. Shareholders of record on Monday, January 15th were issued a dividend of $0.7422 per share. This represents a $2.97 annualized dividend and a yield of 11.15%. The ex-dividend date of this dividend was Thursday, January 11th.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.